$70M Risperdal Verdict
In the Philly Inquirer July 2, 2016: Philadelphia jury pins $70m verdict on Janssen for its Risperdal drug A Philadelphia jury found Friday that the antipsychotic drug Risperdal caused a Tennessee boy to grow breasts and imposed a $70 million verdict on its manufacturer, Janssen Pharmaceuticals. Lawyers for the boy argued that scientists for the […]
Risperdal News: Sheller Quoted in Toronto Star
Stephen Sheller was quoted in a July 31, 2015 article discussing Risperdal research that was “manipulated by a drug company and understated the risks of a powerful antipsychotic used to treat kids with behavioural problems.” In the news story, pediatrician Denis Daneman says there was no intent on his part to exclude “significant results” from […]
TV: SHELLER ON PHARMA & COURTS
Stephen Sheller appeared on the Philadelphia CNN-News affiliate WFMZ-TV program The American Law Journal on “How Is Pharma Faring in the Courts?” Host Christopher Naughton welcomed plaintiff’s attorneys Christopher Placitella, Esq. of Cohen Placitella & Roth, Stephen Sheller of Sheller, P.C., corporate defense counsel Terry Henry of Blank Rome and Bloomberg News Reporter Jef Feeley. In an opening feature report, […]
HUMANITARIAN OF THE YEAR, CCHR
Stephen Sheller was honored as “Humanitarian of the Year” by the Citizens Commission on Human Rights (CCHR). The black tie event was held at the Los Angeles Westin Bonaventure February 28, 2015. The introduction to his award: “CCHR’s first human rights award winner is a renowned attorney Stephen Sheller. His Philadelphia law firm opposes some […]
$2.5 Million Verdict
A Philadelphia jury awarded $2.5 million to a twenty year old man whose family claimed he developed female-like breasts (gynecomastia) from taking the antipsychotic drug Risperdal for five years from ages eight to thirteen. Stephen A. Sheller, attorney for the family: “We are encouraged to see this day come, after ten years of our pursuing […]
$58.9 MILLION SETTLEMENT
The Sheller whistleblower team announced a $58.9 milllion settlement with Shire Pharmaceuticals over off-label marketing of ADHD drugs Adderall and Vyvanse in September, 2014. Court documents detailing the civil allegations and settlement were signed by Shire and unsealed by the Office of the United States Attorney for the Eastern District of Pennsylvania. A Shire executive, […]
$1.4 Billion Settlement
Philadelphia Attorney Stephen Sheller’s Whistleblower Clients Help Government Recover $1.4 Billion Record Settlement and Criminal Fine in Eli Lilly & Company Zyprexa® Marketing Case Lead Attorney Filed Complaint in 2003 Representing Six Whistleblowers Pharmaceutical giant Eli Lilly & Company (“Lilly”) agreed to pay federal and state governments more than $1.4 billion in January 2009 to […]
